{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T13:34:13Z","timestamp":1762263253778,"version":"build-2065373602"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,4]]},"DOI":"10.7759\/cureus.96074","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T13:31:25Z","timestamp":1762263085000},"source":"Crossref","is-referenced-by-count":0,"title":["Molecular Mechanisms of Glucocorticoid Action in Migraine: A Systematic Review of Neuroinflammatory and Vascular Pathways"],"prefix":"10.7759","author":[{"given":"Luciano","family":"da Silva Lopes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abouch","family":"Krymchantowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Jevoux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Gabriela","family":"Krymchantowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camila M","family":"Maria Coelho de Moura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana A","family":"Soares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco Ant\u00f4nio Pereira de","family":"S\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina Nayara de Ara\u00fajo","family":"Val","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renato Mendes dos","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raimundo Pereira","family":"Silva-N\u00e9to","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30322-3","article-title":"Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"17","year":"2018","unstructured":"Global, regional, and national burden of migraine and tension-type headache, 1990-2016. a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018, 17:954-76. 10.1016\/S1474-4422(18)30322-3","journal-title":"Lancet Neurol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2019.06.001","article-title":"Migraine: epidemiology, burden, and comorbidity","volume":"37","author":"Burch RC","year":"2019","unstructured":"Burch RC, Buse DC, Lipton RB. Migraine: epidemiology, burden, and comorbidity. Neurol Clin. 2019, 37:631-49. 10.1016\/j.ncl.2019.06.001","journal-title":"Neurol Clin"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.14243","article-title":"Migraine triggers: an overview of the pharmacology, biochemistry, atmospherics, and their effects on neural networks","volume":"13","author":"Kesserwani H","year":"2021","unstructured":"Kesserwani H. Migraine triggers: an overview of the pharmacology, biochemistry, atmospherics, and their effects on neural networks. Cureus. 2021, 13:e14243. 10.7759\/cureus.14243","journal-title":"Cureus"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/0333102416636098","article-title":"May headache triggered by odors be regarded as a differentiating factor between migraine and other primary headaches?","volume":"37","author":"Silva-N\u00e9to RP","year":"2017","unstructured":"Silva-N\u00e9to RP, Rodrigues \u00c2B, Cavalcante DC, et al.. May headache triggered by odors be regarded as a differentiating factor between migraine and other primary headaches?. Cephalalgia. 2017, 37:20-8. 10.1177\/0333102416636098","journal-title":"Cephalalgia"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-013-0368-1","article-title":"How does fasting trigger migraine? A hypothesis","volume":"17","author":"Dalkara T","year":"2013","unstructured":"Dalkara T, Kili\u00e7 K. How does fasting trigger migraine? A hypothesis. Curr Pain Headache Rep. 2013, 17:368. 10.1007\/s11916-013-0368-1","journal-title":"Curr Pain Headache Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s40519-020-00984-7","article-title":"Fruit and vegetable consumption in relation to primary headaches: the MEPHASOUS study","volume":"26","author":"Mansouri M","year":"2021","unstructured":"Mansouri M, Sharifi F, Varmaghani M, Shokri A, Rahdar H, Keshtkar A, Sadeghi O. Fruit and vegetable consumption in relation to primary headaches: the MEPHASOUS study. Eat Weight Disord. 2021, 26:1617-26. 10.1007\/s40519-020-00984-7","journal-title":"Eat Weight Disord"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2021.1862650","article-title":"Polyamines serum levels in episodic and chronic migraine","volume":"21","author":"Lionetto L","year":"2021","unstructured":"Lionetto L, Guglielmetti M, Cipolla F, et al.. Polyamines serum levels in episodic and chronic migraine. Expert Rev Neurother. 2021, 21:249-54. 10.1080\/14737175.2021.1862650","journal-title":"Expert Rev Neurother"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1159\/000531286","article-title":"Migraine attacks triggered by ingestion of watermelon","volume":"86","author":"Silva-N\u00e9to RP","year":"2023","unstructured":"Silva-N\u00e9to RP, Bezerra GL, Ara\u00fajo NR, et al.. Migraine attacks triggered by ingestion of watermelon. Eur Neurol. 2023, 86:250-5. 10.1159\/000531286","journal-title":"Eur Neurol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15657","article-title":"Pharmacological treatment of migraine: drug classes, mechanisms of action, clinical trials and new treatments","volume":"178","author":"Zobdeh F","year":"2021","unstructured":"Zobdeh F, Ben Kraiem A, Attwood MM, Chubarev VN, Tarasov VV, Schi\u00f6th HB, Mwinyi J. Pharmacological treatment of migraine: drug classes, mechanisms of action, clinical trials and new treatments. Br J Pharmacol. 2021, 178:4588-607. 10.1111\/bph.15657","journal-title":"Br J Pharmacol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-023-11706-1","article-title":"Migraine: from pathophysiology to treatment","volume":"270","author":"Puledda F","year":"2023","unstructured":"Puledda F, Silva EM, Suwanlaong K, Goadsby PJ. Migraine: from pathophysiology to treatment. J Neurol. 2023, 270:3654-66. 10.1007\/s00415-023-11706-1","journal-title":"J Neurol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241512268","article-title":"Migraine treatment: towards new pharmacological targets","volume":"24","author":"Silvestro M","year":"2023","unstructured":"Silvestro M, Iannone LF, Orologio I, Tessitore A, Tedeschi G, Geppetti P, Russo A. Migraine treatment: towards new pharmacological targets. Int J Mol Sci. 2023, 24:12268. 10.3390\/ijms241512268","journal-title":"Int J Mol Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2023.108523","article-title":"Towards precision medicine in migraine: recent therapeutic advances and potential biomarkers to understand heterogeneity and treatment response","volume":"250","author":"Juhasz G","year":"2023","unstructured":"Juhasz G, Gecse K, Baksa D. Towards precision medicine in migraine: recent therapeutic advances and potential biomarkers to understand heterogeneity and treatment response. Pharmacol Ther. 2023, 250:108523. 10.1016\/j.pharmthera.2023.108523","journal-title":"Pharmacol Ther"},{"key":"ref13","doi-asserted-by":"crossref","DOI":"10.2147\/nedt.2006.2.3.293","article-title":"The use of combination therapies in the acute management of migraine","volume":"2","author":"Krymchantowski AV","year":"2006","unstructured":"Krymchantowski AV. The use of combination therapies in the acute management of migraine. Neuropsychiatr Dis Treat. 2006, 2:293-7.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39566.806725.BE","article-title":"Parenteral dexamethasone for acute severe migraine headache: meta-analysis of randomised controlled trials for preventing recurrence","volume":"336","author":"Colman I","year":"2008","unstructured":"Colman I, Friedman BW, Brown MD, Innes GD, Grafstein E, Roberts TE, Rowe BH. Parenteral dexamethasone for acute severe migraine headache: meta-analysis of randomised controlled trials for preventing recurrence. BMJ. 2008, 336:1359-61. 10.1136\/bmj.39566.806725.BE","journal-title":"BMJ"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3810\/pgm.2012.05.2554","article-title":"Role of dexamethasone in the prevention of migraine recurrence in the acute care setting: a review","volume":"124","author":"Giuliano C","year":"2012","unstructured":"Giuliano C, Smalligan RD, Mitchon G, Chua M. Role of dexamethasone in the prevention of migraine recurrence in the acute care setting: a review. Postgrad Med. 2012, 124:110-5. 10.3810\/pgm.2012.05.2554","journal-title":"Postgrad Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/head.13999","article-title":"Migraine treatment in emergency departments of Brazil: a retrospective study of 2 regions","volume":"60","author":"Krymchantowski A","year":"2020","unstructured":"Krymchantowski A, Jevoux C, Silva-N\u00e9to RP, Krymchantowski AG. Migraine treatment in emergency departments of Brazil: a retrospective study of 2 regions. Headache. 2020, 60:2413-20. 10.1111\/head.13999","journal-title":"Headache"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2014.01.040","article-title":"Accuracy of osmophobia in the differential diagnosis between migraine and tension-type headache","volume":"339","author":"Silva-N\u00e9to RP","year":"2014","unstructured":"Silva-N\u00e9to RP, Peres MF, Valen\u00e7a MM. Accuracy of osmophobia in the differential diagnosis between migraine and tension-type headache. J Neurol Sci. 2014, 339:118-22. 10.1016\/j.jns.2014.01.040","journal-title":"J Neurol Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.18071\/isz.75.0341","article-title":"Assessment of serum MMP-9, TIMP-1 levels and MMP-9\/TIMP-1 ratio in migraine patients with and without aura","volume":"75","author":"Karademir F","year":"2022","unstructured":"Karademir F, Ozturk M, Altunkaynak Y, Doventas Y, Mutluay B, Basoglu Koseahmet F, Baybas S. Assessment of serum MMP-9, TIMP-1 levels and MMP-9\/TIMP-1 ratio in migraine patients with and without aura. Ideggyogy Sz. 2022, 75:341-9. 10.18071\/isz.75.0341","journal-title":"Ideggyogy Sz"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2009.02654.x","article-title":"Prednisolone reduces nitric oxide-induced migraine","volume":"16","author":"Tfelt-Hansen P","year":"2009","unstructured":"Tfelt-Hansen P, Daugaard D, Lassen LH, Iversen HK, Olesen J. Prednisolone reduces nitric oxide-induced migraine. Eur J Neurol. 2009, 16:1106-11. 10.1111\/j.1468-1331.2009.02654.x","journal-title":"Eur J Neurol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1177\/0333102414539057","article-title":"Corticosteroids alter CGRP and melatonin release in cluster headache episodes","volume":"35","author":"Neeb L","year":"2015","unstructured":"Neeb L, Anders L, Euskirchen P, Hoffmann J, Israel H, Reuter U. Corticosteroids alter CGRP and melatonin release in cluster headache episodes. Cephalalgia. 2015, 35:317-26. 10.1177\/0333102414539057","journal-title":"Cephalalgia"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/ene.12155","article-title":"Steroids for preventing recurrence of acute severe migraine headaches: a meta-analysis","volume":"20","author":"Huang Y","year":"2013","unstructured":"Huang Y, Cai X, Song X, Tang H, Huang Y, Xie S, Hu Y. Steroids for preventing recurrence of acute severe migraine headaches: a meta-analysis. Eur J Neurol. 2013, 20:1184-90. 10.1111\/ene.12155","journal-title":"Eur J Neurol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1172\/JCI21227","article-title":"Cortical spreading depression activates and upregulates MMP-9","volume":"113","author":"Gursoy-Ozdemir Y","year":"2004","unstructured":"Gursoy-Ozdemir Y, Qiu J, Matsuoka N, et al.. Cortical spreading depression activates and upregulates MMP-9. J Clin Invest. 2004, 113:1447-55. 10.1172\/JCI21227","journal-title":"J Clin Invest"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2008.01667.x","article-title":"Differential effects of corticosteroids on the expression of cyclooxygenase-2, tumour necrosis factor-alpha and matrix metalloproteinase-9 in an animal model of migraine","volume":"28","author":"Kim GM","year":"2008","unstructured":"Kim GM, Jin KS, Chung CS. Differential effects of corticosteroids on the expression of cyclooxygenase-2, tumour necrosis factor-alpha and matrix metalloproteinase-9 in an animal model of migraine. Cephalalgia. 2008, 28:1179-87. 10.1111\/j.1468-2982.2008.01667.x","journal-title":"Cephalalgia"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-016-0609-x","article-title":"Methylprednisolone blocks interleukin 1 beta induced calcitonin gene related peptide release in trigeminal ganglia cells","volume":"17","author":"Neeb L","year":"2016","unstructured":"Neeb L, Hellen P, Hoffmann J, Dirnagl U, Reuter U. Methylprednisolone blocks interleukin 1 beta induced calcitonin gene related peptide release in trigeminal ganglia cells. J Headache Pain. 2016, 17:19. 10.1186\/s10194-016-0609-x","journal-title":"J Headache Pain"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/s0197-0186(01)00094-8","article-title":"Substance P and calcitonin gene-related peptide increase IL-1 beta, IL-6 and TNF alpha secretion from human peripheral blood mononuclear cells","volume":"40","author":"Cuesta MC","year":"2002","unstructured":"Cuesta MC, Quintero L, Pons H, Suarez-Roca H. Substance P and calcitonin gene-related peptide increase IL-1 beta, IL-6 and TNF alpha secretion from human peripheral blood mononuclear cells. Neurochem Int. 2002, 40:301-6. 10.1016\/s0197-0186(01)00094-8","journal-title":"Neurochem Int"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3390\/cells11172767","article-title":"Pathophysiology and therapy of associated features of migraine","volume":"11","author":"Villar-Martinez MD","year":"2022","unstructured":"Villar-Martinez MD, Goadsby PJ. Pathophysiology and therapy of associated features of migraine. Cells. 2022, 11:2767. 10.3390\/cells11172767","journal-title":"Cells"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00059.2021","article-title":"CGRP physiology, pharmacology, and therapeutic targets: migraine and beyond","volume":"103","author":"Russo AF","year":"2023","unstructured":"Russo AF, Hay DL. CGRP physiology, pharmacology, and therapeutic targets: migraine and beyond. Physiol Rev. 2023, 103:1565-644. 10.1152\/physrev.00059.2021","journal-title":"Physiol Rev"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00328-4","article-title":"Migraine","volume":"8","author":"Ferrari MD","year":"2022","unstructured":"Ferrari MD, Goadsby PJ, Burstein R, et al.. Migraine. Nat Rev Dis Primers. 2022, 8:2. 10.1038\/s41572-021-00328-4","journal-title":"Nat Rev Dis Primers"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurol.2021.06.003","article-title":"CGRP and migraine: from bench to bedside","volume":"177","author":"Edvinsson L","year":"2021","unstructured":"Edvinsson L. CGRP and migraine: from bench to bedside. Rev Neurol (Paris). 2021, 177:785-90. 10.1016\/j.neurol.2021.06.003","journal-title":"Rev Neurol (Paris)"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.930383","article-title":"CGRP and migraine: what have we learned from measuring cgrp in migraine patients so far?","volume":"13","author":"Kamm K","year":"2022","unstructured":"Kamm K. CGRP and migraine: what have we learned from measuring cgrp in migraine patients so far?. Front Neurol. 2022, 13:930383. 10.3389\/fneur.2022.930383","journal-title":"Front Neurol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1097\/WNO.0000000000000875","article-title":"Biochemical modulation and pathophysiology of migraine","volume":"39","author":"Chan C","year":"2019","unstructured":"Chan C, Wei DY, Goadsby PJ. Biochemical modulation and pathophysiology of migraine. J Neuroophthalmol. 2019, 39:470-9. 10.1097\/WNO.0000000000000875","journal-title":"J Neuroophthalmol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-024-04114-7","article-title":"Oxidative stress and migraine","volume":"61","author":"Jim\u00e9nez-Jim\u00e9nez FJ","year":"2024","unstructured":"Jim\u00e9nez-Jim\u00e9nez FJ, Alonso-Navarro H, Garc\u00eda-Mart\u00edn E, Espada-Rubio S, Ag\u00fandez JA. Oxidative stress and migraine. Mol Neurobiol. 2024, 61:8344-60. 10.1007\/s12035-024-04114-7","journal-title":"Mol Neurobiol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1586\/ern.09.103","article-title":"CSD, BBB and MMP-9 elevations: animal experiments versus clinical phenomena in migraine","volume":"9","author":"Gupta VK","year":"2009","unstructured":"Gupta VK. CSD, BBB and MMP-9 elevations: animal experiments versus clinical phenomena in migraine. Expert Rev Neurother. 2009, 9:1595-614. 10.1586\/ern.09.103","journal-title":"Expert Rev Neurother"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra050541","article-title":"Antiinflammatory action of glucocorticoids--new mechanisms for old drugs","volume":"353","author":"Rhen T","year":"2005","unstructured":"Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids--new mechanisms for old drugs. N Engl J Med. 2005, 353:1711-23. 10.1056\/NEJMra050541","journal-title":"N Engl J Med"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2017.10.010","article-title":"Therapeutic mechanisms of glucocorticoids","volume":"29","author":"Vandewalle J","year":"2018","unstructured":"Vandewalle J, Luypaert A, De Bosscher K, Libert C. Therapeutic mechanisms of glucocorticoids. Trends Endocrinol Metab. 2018, 29:42-54. 10.1016\/j.tem.2017.10.010","journal-title":"Trends Endocrinol Metab"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.06314","article-title":"Clinical pharmacology of corticosteroids","volume":"63","author":"Williams DM","year":"2018","unstructured":"Williams DM. Clinical pharmacology of corticosteroids. Respir Care. 2018, 63:655-70. 10.4187\/respcare.06314","journal-title":"Respir Care"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-021-01271-1","article-title":"Migraine and neuroinflammation: the inflammasome perspective","volume":"22","author":"Kursun O","year":"2021","unstructured":"Kursun O, Yemisci M, van den Maagdenberg AM, Karatas H. Migraine and neuroinflammation: the inflammasome perspective. J Headache Pain. 2021, 22:55. 10.1186\/s10194-021-01271-1","journal-title":"J Headache Pain"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241511993","article-title":"Molecular mechanisms of migraine: nitric oxide synthase and neuropeptides","volume":"24","author":"Karsan N","year":"2023","unstructured":"Karsan N, Gosalia H, Goadsby PJ. Molecular mechanisms of migraine: nitric oxide synthase and neuropeptides. Int J Mol Sci. 2023, 24:10.3390\/ijms241511993","journal-title":"Int J Mol Sci"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1136\/bmjebm-2017-110853","article-title":"Methodological quality and synthesis of case series and case reports","volume":"23","author":"Murad MH","year":"2018","unstructured":"Murad MH, Sultan S, Haffar S, Bazerbachi F. Methodological quality and synthesis of case series and case reports. BMJ Evid Based Med. 2018, 23:60-3. 10.1136\/bmjebm-2017-110853","journal-title":"BMJ Evid Based Med"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1177\/0333102414566200","article-title":"The place of corticosteroids in migraine attack management: a 65-year systematic review with pooled analysis and critical appraisal","volume":"35","author":"Woldeamanuel YW","year":"2015","unstructured":"Woldeamanuel YW, Rapoport AM, Cowan RP. The place of corticosteroids in migraine attack management: a 65-year systematic review with pooled analysis and critical appraisal. Cephalalgia. 2015, 35:996-1024. 10.1177\/0333102414566200","journal-title":"Cephalalgia"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1177\/2040622320939793","article-title":"Endogenous glucocorticoids may serve as biomarkers for migraine chronification","volume":"11","author":"Woldeamanuel YW","year":"2020","unstructured":"Woldeamanuel YW, Sanjanwala BM, Cowan RP. Endogenous glucocorticoids may serve as biomarkers for migraine chronification. Ther Adv Chronic Dis. 2020, 11:2040622320939793. 10.1177\/2040622320939793","journal-title":"Ther Adv Chronic Dis"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-023-01567-4","article-title":"Future targets for migraine treatment beyond CGRP","volume":"24","author":"Al-Hassany L","year":"2023","unstructured":"Al-Hassany L, Boucherie DM, Creeney H, et al.. Future targets for migraine treatment beyond CGRP. J Headache Pain. 2023, 24:76. 10.1186\/s10194-023-01567-4","journal-title":"J Headache Pain"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1172\/JCI182556","article-title":"Meningeal lymphatic vessel dysfunction driven by CGRP signaling causes migraine-like pain in mice","volume":"134","author":"Thomas JL","year":"2024","unstructured":"Thomas JL, Schindler EA, Gottschalk C. Meningeal lymphatic vessel dysfunction driven by CGRP signaling causes migraine-like pain in mice. J Clin Invest. 2024, 134:10.1172\/JCI182556","journal-title":"J Clin Invest"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12618","article-title":"CGRP receptor antagonists and antibodies against CGRP and its receptor in migraine treatment","volume":"80","author":"Edvinsson L","year":"2015","unstructured":"Edvinsson L. CGRP receptor antagonists and antibodies against CGRP and its receptor in migraine treatment. Br J Clin Pharmacol. 2015, 80:193-9. 10.1111\/bcp.12618","journal-title":"Br J Clin Pharmacol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105946","article-title":"Role of PACAP in migraine: an alternative to CGRP?","volume":"176","author":"Guo S","year":"2023","unstructured":"Guo S, Jansen-Olesen I, Olesen J, Christensen SL. Role of PACAP in migraine: an alternative to CGRP?. Neurobiol Dis. 2023, 176:105946. 10.1016\/j.nbd.2022.105946","journal-title":"Neurobiol Dis"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.3390\/neurolint15030067","article-title":"Migraine: advances in the pathogenesis and treatment","volume":"15","author":"Ple\u0219 H","year":"2023","unstructured":"Ple\u0219 H, Florian IA, Timis TL, et al.. Migraine: advances in the pathogenesis and treatment. Neurol Int. 2023, 15:1052-105. 10.3390\/neurolint15030067","journal-title":"Neurol Int"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/409489-molecular-mechanisms-of-glucocorticoid-action-in-migraine-a-systematic-review-of-neuroinflammatory-and-vascular-pathways","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T13:31:26Z","timestamp":1762263086000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/409489-molecular-mechanisms-of-glucocorticoid-action-in-migraine-a-systematic-review-of-neuroinflammatory-and-vascular-pathways"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,4]]},"references-count":46,"URL":"https:\/\/doi.org\/10.7759\/cureus.96074","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,4]]}}}